
Home » BIOPURE CORP. Q2 LOSS NARROWS DESPITE LOWER REVENUES
BIOPURE CORP. Q2 LOSS NARROWS DESPITE LOWER REVENUES
Thursday morning, Biopure Corporation, a developer, manufacturer and marketer of pharmaceuticals, announced financial results for the second quarter reporting net loss that narrowed year-over-year despite lower revenues.
Trading Markets
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
08Sep
-
15Sep
-
20Sep
-
21Sep
-
22Sep
-
11Oct